Mechanisms underlying the J-curve for diastolic blood pressure: Subclinical myocardial injury and immune activation.

MedStar author(s):
Citation: International Journal of Cardiology. 276:255-260, 2019 Feb 01.PMID: 30217423Institution: MedStar Health Research InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Blood Pressure/ph [Physiology] | *Coronary Artery Disease/pp [Physiopathology] | *Immunity, Innate/ph [Physiology] | *Inflammation Mediators/bl [Blood] | *Receptors, Urokinase Plasminogen Activator/bl [Blood] | Aged | Biomarkers/bl [Blood] | Coronary Artery Disease/bl [Blood] | Diastole | Female | Follow-Up Studies | Humans | Male | Middle Aged | Prognosis | Prospective Studies | Risk Factors | Time FactorsYear: 2019ISSN:
  • 0167-5273
Name of journal: International journal of cardiologyAbstract: BACKGROUND: Low diastolic blood pressure (DBP) is associated with increased risk of cardiovascular events. In patients with coronary artery disease (CAD), limitations in coronary blood flow and immune activity are implicated mechanisms, but evidence is lacking. We investigated the association between DBP, biomarkers of myocardial injury, inflammation, immune activation and incident events in patients with CAD.CONCLUSION: In patients with CAD, DBP<60mmHg is associated with subclinical myocardial injury, immune/inflammatory dysregulation and incident events. Aggressive BP control may be harmful in these patients, and further investigation is warranted to determine appropriate BP targets in patients with CAD.Copyright (c) 2018. Published by Elsevier B.V.METHODS: We studied 2448 adults (mean age 65+/-12years, 68% male, median follow-up 4.5years) with CAD. DBP was categorized into 10mmHg increments. Biomarkers of myocardial injury (high sensitivity cardiac troponin-I [hs-cTnI]) and immune activity/inflammation (soluble urokinase plasminogen activator receptor [suPAR]) were dichotomized at their median values. DBP 70-79mmHg was used as the referent group, and individuals were followed prospectively for adverse outcomes.RESULTS: After adjusting for demographic and clinical covariates, individuals with DBP<60mmHg had increased odds of elevated levels of hs-cTnI (OR=1.68; 95% CI=1.07, 2.65) and suPAR (OR=1.71; 95% CI=1.10, 2.65) compared to the referent group. Additionally, DBP<60mmHg was associated with increased adjusted risk of cardiovascular death or MI (HR=2.04; 95% CI=1.32, 3.16) and all-cause mortality (HR=2.41; 95% CI=1.69, 3.45).All authors: Alkhoder A, Epstein SE, Gafeer MM, Hayek SS, Kim JH, Ko YA, O'Neal WT, Quyyumi AA, Sandesara PB, Shaw LJ, Sperling LS, Stahl EP, Tahhan AS, Topel ML, Vaccarino V, Wilson PWFFiscal year: FY2019Digital Object Identifier: Date added to catalog: 2018-09-28
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 30217423 Available 30217423

BACKGROUND: Low diastolic blood pressure (DBP) is associated with increased risk of cardiovascular events. In patients with coronary artery disease (CAD), limitations in coronary blood flow and immune activity are implicated mechanisms, but evidence is lacking. We investigated the association between DBP, biomarkers of myocardial injury, inflammation, immune activation and incident events in patients with CAD.

CONCLUSION: In patients with CAD, DBP<60mmHg is associated with subclinical myocardial injury, immune/inflammatory dysregulation and incident events. Aggressive BP control may be harmful in these patients, and further investigation is warranted to determine appropriate BP targets in patients with CAD.

Copyright (c) 2018. Published by Elsevier B.V.

METHODS: We studied 2448 adults (mean age 65+/-12years, 68% male, median follow-up 4.5years) with CAD. DBP was categorized into 10mmHg increments. Biomarkers of myocardial injury (high sensitivity cardiac troponin-I [hs-cTnI]) and immune activity/inflammation (soluble urokinase plasminogen activator receptor [suPAR]) were dichotomized at their median values. DBP 70-79mmHg was used as the referent group, and individuals were followed prospectively for adverse outcomes.

RESULTS: After adjusting for demographic and clinical covariates, individuals with DBP<60mmHg had increased odds of elevated levels of hs-cTnI (OR=1.68; 95% CI=1.07, 2.65) and suPAR (OR=1.71; 95% CI=1.10, 2.65) compared to the referent group. Additionally, DBP<60mmHg was associated with increased adjusted risk of cardiovascular death or MI (HR=2.04; 95% CI=1.32, 3.16) and all-cause mortality (HR=2.41; 95% CI=1.69, 3.45).

English

Powered by Koha